Afimoxifene Completed Phase 2 Trials for Estrogen Receptor Positive Breast Cancer / Ductal Breast Carcinoma In Situ / Estrogen Receptor-Positive Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ